These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20458577)

  • 21. Clinical performance of osteoporosis risk assessment tools in women aged 67 years and older.
    Gourlay ML; Powers JM; Lui LY; Ensrud KE;
    Osteoporos Int; 2008 Aug; 19(8):1175-83. PubMed ID: 18219434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Number of osteoporotic sites and fracture risk assessment: a cohort study from the Manitoba Bone Density Program.
    Leslie WD; Tsang JF; Caetano PA; Lix LM;
    J Bone Miner Res; 2007 Mar; 22(3):476-83. PubMed ID: 17144788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low bone mineral density and fracture burden in postmenopausal women.
    Cranney A; Jamal SA; Tsang JF; Josse RG; Leslie WD
    CMAJ; 2007 Sep; 177(6):575-80. PubMed ID: 17846439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model.
    Si L; Winzenberg TM; Jiang Q; Palmer AJ
    Osteoporos Int; 2015 May; 26(5):1477-89. PubMed ID: 25567776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnostic threshold for osteoporosis impedes fracture prevention in women at high risk for fracture: A registry-based cohort study.
    Leslie WD; Seeman E; Morin SN; Lix LM; Majumdar SR
    Bone; 2018 Sep; 114():298-303. PubMed ID: 30008396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone health-related factors and the use of bisphosphonates in community setting--15-year follow-up study.
    Sirola J; Salovaara K; Rikkonen T; Kärkkäinen M; Tuppurainen M; Jurvelin JS; Honkanen R; Kröger H
    Osteoporos Int; 2011 Jan; 22(1):255-64. PubMed ID: 20422155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of decision rules to identify postmenopausal women for intervention related to osteoporosis.
    Brenneman SK; Lacroix AZ; Buist DS; Chen YT; Abbott TA
    Dis Manag; 2003; 6(3):159-68. PubMed ID: 14570384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of implementing guidelines for the treatment of glucocorticoid-induced osteoporosis in Japan.
    Moriwaki K; Fukuda H
    Osteoporos Int; 2019 Feb; 30(2):299-310. PubMed ID: 30610244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population screening for osteoporosis risk: a randomised control trial of medication use and fracture risk.
    Barr RJ; Stewart A; Torgerson DJ; Reid DM
    Osteoporos Int; 2010 Apr; 21(4):561-8. PubMed ID: 19565176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA.
    Wright NC; Saag KG; Dawson-Hughes B; Khosla S; Siris ES
    Osteoporos Int; 2017 Apr; 28(4):1225-1232. PubMed ID: 27966104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday.
    Xu LH; Adams-Huet B; Poindexter JR; Maalouf NM
    Osteoporos Int; 2016 May; 27(5):1701-8. PubMed ID: 26642963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of an algorithm to detect severe MS relapses in administrative health databases.
    Marriott JJ; Chen H; Fransoo R; Marrie RA
    Mult Scler Relat Disord; 2018 Jan; 19():134-139. PubMed ID: 29223870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteoporosis treatment considerations based upon fracture history, fracture risk assessment, vertebral fracture assessment, and bone density in Canada.
    Leslie WD; Lix LM; Binkley N
    Arch Osteoporos; 2020 Jun; 15(1):93. PubMed ID: 32577922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of a fracture liaison service--a real-world evaluation after 6 years of service provision.
    Yong JH; Masucci L; Hoch JS; Sujic R; Beaton D
    Osteoporos Int; 2016 Jan; 27(1):231-40. PubMed ID: 26275439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of fracture prevention in rural women with limited access to dual-energy X-ray absorptiometry.
    Ito K; Leslie WD
    Osteoporos Int; 2015 Aug; 26(8):2111-9. PubMed ID: 25807913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of socioeconomic status on bone density testing in a public health-care system.
    Demeter S; Leslie WD; Lix L; MacWilliam L; Finlayson GS; Reed M
    Osteoporos Int; 2007 Feb; 18(2):153-8. PubMed ID: 17019518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Change in Trabecular Bone Score (TBS) With Antiresorptive Therapy Does Not Predict Fracture in Women: The Manitoba BMD Cohort.
    Leslie WD; Majumdar SR; Morin SN; Hans D; Lix LM
    J Bone Miner Res; 2017 Mar; 32(3):618-623. PubMed ID: 27933656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of an administrative definition for celiac disease.
    Duerksen DR; Lix LM; Leslie WD
    BMC Res Notes; 2019 Oct; 12(1):661. PubMed ID: 31623688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years.
    Ferrari S; Adachi JD; Lippuner K; Zapalowski C; Miller PD; Reginster JY; Törring O; Kendler DL; Daizadeh NS; Wang A; O'Malley CD; Wagman RB; Libanati C; Lewiecki EM
    Osteoporos Int; 2015 Dec; 26(12):2763-71. PubMed ID: 26068295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.
    McClung MR; Lippuner K; Brandi ML; Zanchetta JR; Bone HG; Chapurlat R; Hans D; Wang A; Zapalowski C; Libanati C
    Osteoporos Int; 2017 Oct; 28(10):2967-2973. PubMed ID: 28748386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.